Cargando…

Novel human antibody therapeutics: The age of the Umabs

Monoclonal antibodies represent a major and increasingly important category of biotechnology products for the treatment of human diseases. The state-of-the-art of antibody technology has evolved to the point where therapeutic monoclonal antibodies, that are practically indistinguishable from antibod...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ruuls, Sigrid R, van Bueren, Jeroen J Lammerts, van de Winkel, Jan G J, Parren, Paul W H I
Formato:	Texto
Lenguaje:	English
Publicado:	WILEY-VCH Verlag 2008
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959493/ https://www.ncbi.nlm.nih.gov/pubmed/18702090 http://dx.doi.org/10.1002/biot.200800110

Ejemplares similares

Antibody-mediated phagocytosis contributes to the anti-tumor activity of the therapeutic antibody daratumumab in lymphoma and multiple myeloma
por: Overdijk, Marije B, et al.
Publicado: (2015)

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond
por: van de Donk, Niels W. C. J., et al.
Publicado: (2016)

Opening the door to innovation
por: Schuurman, Janine, et al.
Publicado: (2014)

Preclinical evaluation of CD38 chimeric antigen receptor engineered T cells for the treatment of multiple myeloma
por: Drent, Esther, et al.
Publicado: (2015)

ToleRability of BevacizUmab in elderly Ovarian cancer patients (TURBO study): a case-control study of a real-life experience
por: Amadio, Giulia, et al.
Publicado: (2019)

Prebiotic galactooligosaccharides activate mucin and pectic galactan utilization pathways in the human gut symbiont Bacteroides thetaiotaomicron
por: Lammerts van Bueren, Alicia, et al.
Publicado: (2017)

HIC2 regulates isoform switching during maturation of the cardiovascular system
por: Dykes, Iain M., et al.
Publicado: (2018)

Corrigendum to “HIC2 regulates isoform switching during maturation of the cardiovascular system” [Journal of Molecular and Cellular Cardiology volume 114 (2018) P29-37/ https://doi.org/10.1016/j.yjmcc.2017.10.007]
por: Dykes, Iain M., et al.
Publicado: (2023)

Towards resilience through systems-based plant breeding. A review
por: Lammerts van Bueren, Edith T., et al.
Publicado: (2018)

Structural Identity of Galactooligosaccharide Molecules Selectively Utilized by Single Cultures of Probiotic Bacterial Strains
por: Böger, Markus, et al.
Publicado: (2019)

Influence of transplant size on the above- and below-ground performance of four contrasting field-grown lettuce cultivars
por: Kerbiriou, P. J., et al.
Publicado: (2013)

Draft Genome Sequence of Lactobacillus reuteri 121, a Source of α-Glucan and β-Fructan Exopolysaccharides
por: Gangoiti, Joana, et al.
Publicado: (2017)

Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more
por: Parren, Paul W. H. I., et al.
Publicado: (2017)

Systematic study of tissue factor expression in solid tumors
por: de Bono, Johann S., et al.
Publicado: (2022)

Editorial: Antibody Therapeutics for the Treatment of Filoviral Infection
por: Murin, Charles D., et al.
Publicado: (2022)

Therapeutic antibody engineering: Current and future advances driving the strongest growth area in the pharmaceutical industry
por: Parren, Paul W.H.I., et al.
Publicado: (2013)

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies
por: van der Veer, M S, et al.
Publicado: (2011)

Genetic Control of Water and Nitrate Capture and Their Use Efficiency in Lettuce (Lactuca sativa L.)
por: Kerbiriou, Pauline J., et al.
Publicado: (2016)

A Novel Platform for the Potentiation of Therapeutic Antibodies Based on Antigen-Dependent Formation of IgG Hexamers at the Cell Surface
por: de Jong, Rob N., et al.
Publicado: (2016)

The antiviral activity of antibodies in vitro and in vivo
por: Parren, Paul W.H.I., et al.
Publicado: (2001)

IgA EGFR antibodies mediate tumour killing in vivo
por: Boross, Peter, et al.
Publicado: (2013)

Association Mapping of Physiological and Morphological Traits Related to Crop Development under Contrasting Nitrogen Inputs in a Diverse Set of Potato Cultivars
por: Ospina Nieto, Cesar A., et al.
Publicado: (2021)

High-Throughput Screening for Internalizing Antibodies by Homogeneous Fluorescence Imaging of a pH-Activated Probe
por: Riedl, Thilo, et al.
Publicado: (2016)

Candidate targets for antibody therapy of rheumatoid arthritis: CD64 and IL-15
por: van de Winkel, J
Publicado: (2003)

Antigen and Cell-Based Assays for the Detection of Non-HLA Antibodies
por: Lammerts, Rosa G. M., et al.
Publicado: (2022)

Variation in Broccoli Cultivar Phytochemical Content under Organic and Conventional Management Systems: Implications in Breeding for Nutrition
por: Renaud, Erica N. C., et al.
Publicado: (2014)

Hes1 expression is reduced in Tbx1 null cells and is required for the development of structures affected in 22q11 deletion syndrome
por: van Bueren, Kelly Lammerts, et al.
Publicado: (2010)

Avidity in antibody effector functions and biotherapeutic drug design
por: Oostindie, Simone C., et al.
Publicado: (2022)

Mycobacterium avium Subspecies paratuberculosis DNA and Antibodies in Dairy Goat Colostrum and Milk
por: Lievaart-Peterson, Karianne, et al.
Publicado: (2019)

Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11–15, 2016, San Diego, CA
por: Larrick, James W., et al.
Publicado: (2016)

Antibody Engineering and Therapeutics Conference: The Annual Meeting of the Antibody Society, December 8–12, 2013, Huntington Beach, CA
por: Almagro, Juan Carlos, et al.
Publicado: (2013)

Recombinant human monoclonal HLA antibodies of different IgG subclasses recognising the same epitope: Excellent tools to study differential effects of donor‐specific antibodies
por: Kramer, Cynthia S. M., et al.
Publicado: (2019)

DuoHexaBody-CD37(®), a novel biparatopic CD37 antibody with enhanced Fc-mediated hexamerization as a potential therapy for B-cell malignancies
por: Oostindie, Simone C., et al.
Publicado: (2020)

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements
por: Schram, Alison M., et al.
Publicado: (2022)

Antibody engineering and therapeutics conference: The annual meeting of the antibody society, Huntington Beach, CA, December 7–11, 2014
por: Larrick, James W, et al.
Publicado: (2014)

Effects of Age and Environment on Adaptive Immune Responses to Mycobacterium avium subsp. paratuberculosis (MAP) Vaccination in Dairy Goats in Relation to Paratuberculosis Control Strategies
por: Koets, Ad, et al.
Publicado: (2019)

Cross-reactive and pre-existing antibodies to therapeutic antibodies—Effects on treatment and immunogenicity
por: van Schie, Karin A, et al.
Publicado: (2015)

Neutralizing Antibody Fails to Impact the Course of Ebola Virus Infection in Monkeys
por: Oswald, Wendelien B, et al.
Publicado: (2007)

In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap
por: Rosati, Sara, et al.
Publicado: (2013)

Enhancement of therapeutic potential of a naturally occurring human antibody targeting a phosphorylated Ser(422) containing epitope on pathological tau
por: van Ameijde, Jeroen, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_up1pttkk68c9q0guc6d2d1qe67